Skip to main content
Erschienen in: Forensic Toxicology 2/2020

01.07.2020 | Original Article

Mass spectrometric characterization of carfentanil metabolism in human, dog, and rat lung microsomes via comparison to chemically synthesized metabolite standards

verfasst von: Li Kong, Andrew J. Walz

Erschienen in: Forensic Toxicology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The metabolism of carfentanil was assessed using human, dog, and rat pulmonary microsomes. Mass spectrometry based analysis allowed for metabolite identification and species differentiation. Participation of different metabolic enzymes in carfentanil biotransformation was also assessed.

Methods

Metabolite profiling was accomplished by incubating 10 µM carfentanil in human, dog, and rat lung microsomes. The metabolites were separated and analyzed by ultra-high performance liquid chromatography/high-resolution mass spectrometry.

Results

In total, 18 metabolites were detected. Nine metabolites were authentically identified through comparison to synthesized reference standards. In human lung microsomes, nine metabolites were identified. In dog lung microsomes, 15 metabolites were identified with three being dog specific. In rat lung microsomes, 15 metabolites were identified and two were rat specific. Proposed metabolic pathways included N-dealkylation, monohydroxylation, dihydroxylation, N-oxidation of piperidine ring nitrogen, and ketone formation. Participation of enzymes CYP2B6, CYP2E1, CYP2J2, and CYP3A4/5 to carfentanil metabolism was suggested by selective enzymatic inhibition.

Conclusions

The pulmonary clearance in human lung microsomes was lower than the previously reported hepatic metabolism suggesting organ specific metabolic rates. The contribution of multiple cytochrome P450 enzymes to human, dog, and rat pulmonary microsomal carfentanil biotransformation varied between species. The identified metabolites may provide useful markers for possible forensic and clinical determination of the mode of ingestion but the use of dog and rat animal models was not indicated. To our knowledge, this is the first reported use of chemically synthesized reference standards for the unequivocal identification of lung carfentanil metabolites.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Schumacher J, Heard DJ, Young L, Citino SB (1997) Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama). J Zoo Wildl Med 28:166–170PubMed Schumacher J, Heard DJ, Young L, Citino SB (1997) Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama). J Zoo Wildl Med 28:166–170PubMed
6.
Zurück zum Zitat Neumann G, Erhardt W, Oberhuber B, Fritsch R, Blümel G (1980) A new highly potent and short-acting analgesic, carfentanil (R33799), in combination with the hypnotic agent, etomidat (R26490), as a method of anaesthesia in guinea-pigs. Res Exp Med 177:135–143. https://doi.org/10.1007/bf01851842 CrossRef Neumann G, Erhardt W, Oberhuber B, Fritsch R, Blümel G (1980) A new highly potent and short-acting analgesic, carfentanil (R33799), in combination with the hypnotic agent, etomidat (R26490), as a method of anaesthesia in guinea-pigs. Res Exp Med 177:135–143. https://​doi.​org/​10.​1007/​bf01851842 CrossRef
10.
Zurück zum Zitat Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ, Newbould RD, Howard J, Miller SR, Bush MA, Hill S, Reiley R, Passchier J, Gunn RN, Matthews PM, Bullmore ET (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16:826–835. https://doi.org/10.1038/mp.2011.29(open access article) CrossRefPubMedPubMedCentral Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ, Newbould RD, Howard J, Miller SR, Bush MA, Hill S, Reiley R, Passchier J, Gunn RN, Matthews PM, Bullmore ET (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16:826–835. https://​doi.​org/​10.​1038/​mp.​2011.​29(open access article) CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DH, Schumann G, Machulla HJ, Bares R, Mann K (2005) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving—a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62:57–64. https://doi.org/10.1001/archpsyc.62.1.57 CrossRefPubMed Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DH, Schumann G, Machulla HJ, Bares R, Mann K (2005) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving—a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62:57–64. https://​doi.​org/​10.​1001/​archpsyc.​62.​1.​57 CrossRefPubMed
13.
Zurück zum Zitat Reimold M, Hermann D, Reischl G, Smolka M, Batra A, Rietschel M, Kiefer F, Heinz A, Bares R, Mann K (2010) Reduced mu-opiate receptor availability in a genetic variant of the mu-opiate receptor (A118G): a [11C] carfentanil PET study. J Nucl Med 51(Suppl. 2):49 (only abstract available) Reimold M, Hermann D, Reischl G, Smolka M, Batra A, Rietschel M, Kiefer F, Heinz A, Bares R, Mann K (2010) Reduced mu-opiate receptor availability in a genetic variant of the mu-opiate receptor (A118G): a [11C] carfentanil PET study. J Nucl Med 51(Suppl. 2):49 (only abstract available)
21.
Zurück zum Zitat Olsson B, Bondesson E, Borgström L, Edsbäcker S, Eirefelt S, Ekelund K, Gustavsson L, Hegelund-Myrbäck T (2011) Pulmonary drug metabolism, clearance, and absorption. In: Smyth HDC, Hickey AJ (eds) Controlled pulmonary drug delivery. Springer, New York Olsson B, Bondesson E, Borgström L, Edsbäcker S, Eirefelt S, Ekelund K, Gustavsson L, Hegelund-Myrbäck T (2011) Pulmonary drug metabolism, clearance, and absorption. In: Smyth HDC, Hickey AJ (eds) Controlled pulmonary drug delivery. Springer, New York
Metadaten
Titel
Mass spectrometric characterization of carfentanil metabolism in human, dog, and rat lung microsomes via comparison to chemically synthesized metabolite standards
verfasst von
Li Kong
Andrew J. Walz
Publikationsdatum
01.07.2020
Verlag
Springer Singapore
Erschienen in
Forensic Toxicology / Ausgabe 2/2020
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-019-00521-x

Weitere Artikel der Ausgabe 2/2020

Forensic Toxicology 2/2020 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin